Wire Stories
722SK magic Enters the Global Appliances Market With the Launch of Its Products Including Bidet on Amazon
SEOUL, South Korea–(BUSINESS WIRE)–#ElectronicBidets—SK magic, a leading home appliances company in South Korea, announced its entry to the global market starting with...
- 698
Reading International Reports Third Quarter 2021 Results and COVID-19 Business Update
92% of our Cinemas are Open Today Delivered Substantial Reduction in Quarterly Net Loss Reduced Global Debt and Improved Stockholder Equity Earnings...
- 690
Kymeta, Intelsat and Fraunhofer IIS Successfully Demonstrate Satellite-Enabled 5G Connectivity for Mobile Communications
Kymeta and Intelsat develop future 5G technologies for satellite-based communications with mobility with Fraunhofer IIS REDMOND, Wash. & MCLEAN, Va.–(BUSINESS WIRE)–#5G–Kymeta (www.kymetacorp.com),...
- 592
Enfusion Announces Third Quarter 2021 Earnings Release Date
NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”), a leading provider of cloud based investment management software and services, today...
- 625
Digiarty Sponsors Drone License Campaign in Occasion of New Release of DJI Mavic 3 (Cine)
CHENGDU, China–(BUSINESS WIRE)–$AUD #digiarty—Digiarty Software, the leading multimedia software company, announced today a Drone License Campaign on the occasion of the new...
- 596
Ittiam Systems Receives a Strategic Investment
The investment is intended to facilitate the delivery of next generation multimedia technologies and solutions BENGALURU, India & SANTA CLARA, Calif.–(BUSINESS WIRE)–#Audio–Ittiam...
- 738
Renesas Expands Lineup of 28nm Cross-Domain Automotive Control Microcontrollers
RH850/U2B MCUs Accelerate ECU Integration for Zone and Domain Control Applications with Improved Performance, Security, and Motor Control Accelerator IP TOKYO–(BUSINESS WIRE)–#EV–Renesas...
- 769
Noxopharm Announces DARRT-2 Clinical Trial in U.S.
Experimental Immunotherapy Cancer Treatment Enters Phase 2 SYDNEY–(BUSINESS WIRE)–#Veyonda–Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its DARRT-2 Phase 2 clinical...
- 755
Titomic to Introduce Large Scale Cold Spray Manufacturing to the United States with US-Based Triton Systems
Titomic has entered into a non-binding agreement with Triton Systems to develop applications in the US marketplace using Titomic’s patented TKF® (Titomic...
- 600
EdiGene Enters Research Collaboration with the University of Wisconsin-Madison on in Vivo RNA Editing Therapies
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious...
